Financial Performance - For the six months ended September 30, 2024, the group's revenue was approximately HKD 200.08 million, a decrease of about HKD 36.93 million or 15.6% compared to HKD 237.01 million for the same period in 2023[1]. - The company reported a loss attributable to equity holders of approximately HKD 630,000, compared to a loss of HKD 13.31 million for the same period in 2023[1]. - Total comprehensive loss for the period amounted to HKD 156,000, compared to HKD 13.19 million in the previous period[4]. - Basic and diluted loss per share was HKD 0.16, compared to HKD 3.26 for the same period last year[4]. - The group reported a pre-tax profit of HKD 19,259 thousand for the six months ended September 30, 2024, compared to HKD 20,868 thousand for the same period in 2023, reflecting a decrease of 7.7%[23]. - The company recorded a revenue of HKD 201 million for the six months ended September 30, 2024, a decrease of 15.6% compared to HKD 237 million for the same period in 2023[37]. - The net loss for the current period was approximately HKD 630,000, significantly reduced from a net loss of HKD 13.1 million in the previous period[37]. - The group’s total tax expense for the period was HKD 2,393 thousand, compared to a tax benefit of HKD 3,584 thousand in the same period last year[26]. Revenue Breakdown - Revenue for the six months ended September 30, 2024, was HKD 200,076 thousand, a decrease of 15.6% compared to HKD 237,010 thousand for the same period in 2023[17]. - Revenue from non-surgical medical beauty services was HKD 170,722 thousand, down from HKD 176,335 thousand year-on-year, representing a decline of 3.5%[22]. - Revenue from skincare products significantly decreased to HKD 29,336 thousand from HKD 60,631 thousand, a drop of 51.6%[22]. - The revenue from mainland China dropped significantly to HKD 5,036 thousand from HKD 21,941 thousand, a decline of 77.0%[17]. Assets and Liabilities - Non-current assets as of September 30, 2024, totaled HKD 195.69 million, slightly down from HKD 196.88 million as of March 31, 2024[7]. - Current assets amounted to HKD 272.98 million, a decrease from HKD 282.56 million as of March 31, 2024[7]. - Current liabilities were HKD 253.94 million, down from HKD 277.98 million as of March 31, 2024[8]. - The total equity value as of September 30, 2024, was HKD 136.61 million, unchanged from HKD 136.76 million as of March 31, 2024[9]. - Trade receivables as of September 30, 2024, amounted to HKD 3,803,000, down from HKD 13,402,000 as of March 31, 2024[33]. - Trade payables as of September 30, 2024, totaled HKD 9,189,000, compared to HKD 10,561,000 as of March 31, 2024[34]. - The company's lease liabilities amounted to approximately HKD 107 million as of September 30, 2024[55]. - The debt-to-equity ratio was approximately 6.7% as of September 30, 2024, down from 9.1% on March 31, 2024[60]. Operational Efficiency - The company has implemented targeted advertising strategies and improved internal management systems to enhance operational efficiency and reduce costs[36]. - Other net expenses decreased by approximately HKD 28.1 million or 35.3% to about HKD 51.4 million, attributed to improved operational efficiency and effective cost control[48]. - Employee costs decreased by approximately HKD 17.3 million or 18.9% to about HKD 74.2 million, with the number of employees reduced from 413 to 242[45]. - Property rental and related expenses decreased by approximately HKD 6 million or 17.2% to about HKD 28.9 million, primarily due to the closure of retail stores[46]. Corporate Governance - The company has adhered to all applicable corporate governance rules during the six-month period ended September 30, 2024, with one exception regarding the separation of the roles of Chairman and CEO[71]. - The Audit Committee, consisting of three independent non-executive directors, has reviewed the financial information for the six months ended September 30, 2024[74]. - The company believes that maintaining high standards of corporate governance is essential for managing business risks and enhancing transparency[71]. Future Outlook - The company plans to introduce new therapies and products to increase brand awareness and market coverage, responding to changing market demands[67]. - The company has adopted a cautious and prudent operational strategy to adapt to structural changes in the consumer market[66]. - The economic environment remains challenging, impacting market sentiment and business operations[36]. - The company has maintained a low debt ratio over the years, ensuring a stable financial position despite a relatively high interest rate environment[66]. Dividends and Shareholder Returns - The board of directors did not declare an interim dividend for the six months ended September 30, 2024, consistent with the previous year[1]. - The group did not declare any interim dividend for the six months ended September 30, 2024, consistent with the same period in 2023[27]. - The company has not engaged in any purchases, sales, or redemptions of its own shares during the six-month period ended September 30, 2024[68]. Employment and Workforce - As of September 30, 2024, the group employed 242 employees, a decrease from 413 employees as of September 30, 2023[64]. - Employee costs for the six months ended September 30, 2024, were approximately HKD 74.2 million, down from HKD 91.5 million for the same period in 2023[64]. Business Operations - The company operates three CosMax+ medical beauty centers in Hong Kong, enhancing its customer base and service offerings[38]. - The XOVĒ skincare product line, developed by a Swiss research team, is marketed through various platforms, including retail stores and e-commerce, despite a challenging retail environment[40].
卓珈控股(01827) - 2025 - 中期业绩